Last updated on August 2011

Treatment With Lenalidomide Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma


Brief description of study

Define maximum tolerable dose of the combination lenalidomide, bendamustine, prednisone.

Clinical Study Identifier: NCT01002703

Find a site near you

Start Over